Phase 4
Completed N=1,013
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
Source: ClinicalTrials.gov NCT01147874 ↗Enrolled (actual)
1,013
Serious AEs
0.0%
Results posted
Jun 2012
Primary outcomePrimary: Percentage of Participants With Psoriatic Arthritis (PsA) Based on Physical Examination, Medical History and Laboratory Results — 30.0 Percentage of participants
Summary
This is a phase 4, multicenter, randomized, non-therapeutic interventional trial in subjects with psoriasis looking for the prevalence of psoriatic arthritis. Subjects will be seen and evaluated by a dermatologist at visit 1 and by a rheumatologist at visit 2. A subset of subjects will then go on to visit 3 for imaging procedures (x-ray, MRI, and ultrasound).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With Psoriatic Arthritis (PsA) Based on Physical Examination, Medical History and Laboratory Results |
30.0 | — |
| SECONDARY Percentage of Participants With Psoriatic Arthritis (PsA) Based on Physical Examination and Medical History |
29.6 | — |
| SECONDARY Percentage of Participants With Undiagnosed Psoriatic Arthritis (PsA) |
12.3; 12.0 | — |
Eligibility Criteria
Inclusion Criteria
- Subject is >18 years of age at the time of consent.
- Subject has a confirmed diagnosis of plaque psoriasis by clinical judgment.
- Subject is able to read and complete questionnaires.
- Subjects planning to undergo radiographic evaluation, should not have any contraindications to MRI.
Exclusion Criteria
- None.
Data sourced from ClinicalTrials.gov (NCT01147874). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.